Svenja Heischmann
Papers
1
Total Citations
49
H-Index
1
About
Svenja Heischmann is a leading figure in bioanalytical chemistry, with a primary focus on the development of high-throughput mass spectrometry methods for therapeutic drug monitoring. Her most cited work, a 2011 paper detailing a U-HPLC–MS/MS assay for quantifying mycophenolic acid and its major metabolites in human plasma and urine, has garnered 49 citations, establishing a gold standard for immunosuppressant analysis. This contribution is critical for optimizing transplant patient care, enabling precise measurement of drug exposure and toxic acyl-glucuronide metabolites. Heischmann’s research bridges clinical pharmacology and analytical innovation, providing robust tools for pharmacokinetic studies. Her impact is further underscored by her expertise in complex matrix analysis, advancing personalized medicine through reliable, high-sensitivity assays. For students and researchers, her work exemplifies how rigorous method development can directly inform clinical decision-making, making her a key reference in bioanalysis and transplant pharmacology.
Research Focus
Key Achievements
Top Papers
- 1